Application Sponsors
ANDA 211505 | TEVA PHARMS USA | |
Marketing Status
Application Products
001 | CAPSULE, DELAYED REL PELLETS;ORAL | EQ 125MG VALPROIC ACID | 0 | DIVALPROEX SODIUM | DIVALPROEX SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-11-17 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
TEVA PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 211505
[companyName] => TEVA PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"DIVALPROEX SODIUM","activeIngredients":"DIVALPROEX SODIUM","strength":"EQ 125MG VALPROIC ACID","dosageForm":"CAPSULE, DELAYED REL PELLETS;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/17\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-11-17
)
)